Delivering on the Vision of Bench to Bedside: A Rare Disease Funding Community Collaboration to Develop Effective Therapies for Neurofibromatosis Type 1 Tumors
S. La Rosa, V. Browder, A. C. Bakker, J. O. Blakeley, S. K. Verma, L. M. Wong, J. A. Morris, N. Bora
The paper analyzes funding efforts by four organizations to accelerate MEK inhibitor development for NF1-associated tumors.
bioRxiv · Feb 19, 2019Scientific Communication & Education